These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29685123)

  • 41. Role and practice evolution for genetic counseling in the genomic era: The experience of Australian and UK genetics practitioners.
    Dwarte T; Barlow-Stewart K; O'Shea R; Dinger ME; Terrill B
    J Genet Couns; 2019 Apr; 28(2):378-387. PubMed ID: 30629777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parents' and patients' perspectives, experiences, and preferences for germline genetic or genomic testing of children with cancer: A systematic review.
    Hunter JD; Hetherington K; Courtney E; Christensen Y; Fuentes-Bolanos N; Bhatia K; Peate M
    Genet Med; 2024 Sep; 26(9):101197. PubMed ID: 38943478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results.
    Howard Sharp KM; Li C; Lu Z; Clark ME; Jurbergs N; Ouma A; Harrison L; Gerhardt E; Taylor L; Hamilton KV; McGee RB; Nuccio R; Hines-Dowell S; Gattuso JS; Pritchard M; Mandrell BN; Tercyak KP; Nichols KE; Johnson LM
    JCO Precis Oncol; 2023 Sep; 7():e2300159. PubMed ID: 37944075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct-to-consumer personal genome testing and cancer risk prediction.
    Bellcross CA; Page PZ; Meaney-Delman D
    Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
    Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
    Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic Counseling in the Era of Genomics: What's all the Fuss about?
    Brett GR; Wilkins EJ; Creed ET; West K; Jarmolowicz A; Valente GM; Prawer Y; Lynch E; Macciocca I
    J Genet Couns; 2018 Sep; 27(5):1010-1021. PubMed ID: 29368275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genomic testing for pancreatic cancer in clinical practice as real-world evidence.
    Hayashi H; Tanishima S; Fujii K; Mori R; Okamura Y; Yanagita E; Matsuoka R; Amano T; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
    Pancreatology; 2018 Sep; 18(6):647-654. PubMed ID: 30055942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Germline whole genome sequencing in pediatric oncology in Denmark-Practitioner perspectives.
    Byrjalsen A; Stoltze UK; Castor A; Wahlberg A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1276. PubMed ID: 32500610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric cancer families' participation in whole-genome sequencing research in Denmark: Parent perspectives.
    Byrjalsen A; Stoltze U; Wadt K; Hjalgrim LL; Gerdes AM; Schmiegelow K; Wahlberg A
    Eur J Cancer Care (Engl); 2018 Nov; 27(6):e12877. PubMed ID: 30016002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screening.
    Cao M; Notini L; Ayres S; Vears DF
    J Genet Couns; 2023 Apr; 32(2):376-386. PubMed ID: 36245433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stability of Attitudes to the Ethical Issues Raised by the Return of Incidental Genomic Research Findings in Children: A Follow-Up Study.
    Fernandez CV; OʼConnell C; Ferguson M; Orr AC; Robitaille JM; Knoppers BM; McMaster CR
    Public Health Genomics; 2015; 18(5):299-308. PubMed ID: 26352440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
    Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
    Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility.
    Ploem MC; Giesbertz NAA; Bredenoord AL; Retèl VP; van Harten WH
    Eur J Cancer; 2023 Jun; 186():22-26. PubMed ID: 37028199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.
    Nehoray B; Slavin TP; Sun CL; Hurley K; King E; Tsang KK; Cervantes A; Mokhnatkin JV; Sand S; Mejia R; Reb A; Samimi G; Gray S; Blazer KR; Weitzel JN
    J Genet Couns; 2022 Oct; 31(5):1164-1172. PubMed ID: 35617031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
    Hamilton JG; Shuk E; Genoff MC; Rodríguez VM; Hay JL; Offit K; Robson ME
    J Oncol Pract; 2017 Jul; 13(7):e590-e601. PubMed ID: 28628391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
    Eddy K; Jordan Z; Stephenson M
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase II study in advanced cancer patients to evaluate the early transition to palliative care (the PREPArE trial): protocol study for a randomized controlled trial.
    do Carmo TM; Paiva BS; de Siqueira MR; da Rosa Lde T; de Oliveira CZ; Nascimento MS; Paiva CE
    Trials; 2015 Apr; 16():160. PubMed ID: 25872950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor Genomic Testing: Identifying Characteristics Associated With Germline Risk for Developing Malignancy.
    Mahon SM
    Clin J Oncol Nurs; 2020 Dec; 24(6):623-626. PubMed ID: 33216058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.